Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study
2021; Elsevier BV; Volume: 22; Issue: 1 Linguagem: Inglês
10.1016/s1473-3099(21)00451-5
ISSN1474-4457
AutoresEric Yuk Fai Wan, Celine Sze Ling Chui, Francisco Tsz Tsun Lai, Esther W. Chan, Xue Li, Vincent Ka Chun Yan, Le Gao, Qiuyan Yu, Ivan Chun Hang Lam, Raccoon Ka Cheong Chun, Benjamin J. Cowling, Wing Chi Fong, Alexander Yuk Lun Lau, Vincent Mok, Frank Ling Fung Chan, Cheuk Kwong Lee, Lot Sze Tao Chan, Dawin Lo, Kui Kai Lau, Ivan Fan‐Ngai Hung, GM Leung, Ian Chi Kei Wong,
Tópico(s)Heparin-Induced Thrombocytopenia and Thrombosis
ResumoBell's palsy is a rare adverse event reported in clinical trials of COVID-19 vaccines. However, to our knowledge no population-based study has assessed the association between the inactivated SARS-CoV-2 vaccines and Bell's palsy. The aim of this study was to evaluate the risk of Bell's palsy after BNT162b2 and CoronaVac vaccination.
Referência(s)